5 Simple Techniques For Antidepressant agent 5
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre study to evaluate a number of intravenous doses of sifalimumab, in adult sufferers with dermatomyositis or polymyositis (NCT00533091). Main trial goals have been To guage the protection and tolerability of sifalimumab in dermatomyositis or polymyositi